Robotic-assisted surgery for rectal cancer: Current state and future perspective

Area of Science:

• Minimally Invasive Surgery
• Surgical Oncology
• Robotic Surgery

Background:

• Minimally invasive surgery (MIS) has seen increased interest, with robotic-assisted laparoscopic surgery (RALS) emerging as a key advancement.
• RALS offers potential benefits for rectal cancer surgery due to its precision in confined spaces.
• The dual-console system in RALS also presents significant opportunities for surgical education.

Purpose of the Study:

• To evaluate the role and potential benefits of Robotic-Assisted Laparoscopic Surgery (RALS) in rectal cancer treatment.
• To explore the implications of RALS in surgical education and its increasing adoption, particularly in Japan following insurance coverage.
• To discuss the current evidence regarding RALS efficacy, especially in challenging patient subgroups.

Main Methods:

• Review of current evidence and literature on Robotic-Assisted Laparoscopic Surgery (RALS) for rectal cancer.
• Analysis of RALS's technical advantages, including precision dissection in pelvic space.
• Consideration of RALS's impact on surgical training and its economic factors.

Main Results:

• Current evidence does not definitively establish RALS superiority over traditional laparoscopic or open surgery for all rectal cancer cases.
• Specific patient subgroups, including those with obesity, male patients, and those undergoing extended procedures, may experience greater benefits from RALS.
• RALS is recognized as an advancement in surgical education, particularly with dual-console systems.

Conclusions:

• Robotic-assisted laparoscopic surgery (RALS) shows promise for rectal cancer, particularly in technically demanding situations.
• Continued technological innovation and competition are expected to improve RALS outcomes and reduce costs.
• Further robust evidence is needed to establish the overall superiority of RALS, but its benefits in specific scenarios are supported.